SCHEMBL7040097

SCHEMBL7040097

CCCCCCCCC(=O)NC(CCCC)(NC(=O)CCCCC)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
HSP90AA1 P07900 1/20 0.50
FAAH O00519 4/20 0.48
HRH3 Q9Y5N1 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPK1 P28482 1/20 0.46
GPR84 Q9NQS5 7/20 0.45
PPARG P37231 7/20 0.45
PPARD Q03181 7/20 0.45
PPARA Q07869 7/20 0.45
HDAC11 Q96DB2 5/20 0.45
TSHR P16473 4/20 0.45
PTPN1 P18031 3/20 0.45
TLR2 O60603 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
FABP4 P15090 2/20 0.45
SLC22A6 Q4U2R8 1/20 0.45
SLC22A8 Q8TCC7 1/20 0.45
ESR1 P03372 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6553971 1.00 ALDH1A1 (0.50) ALDH1A1HSP90AA1FAAHHRH3MEN1
SCHEMBL9305130 0.92 GPR84 (0.55) ALDH1A1MEN1KMT2AGPR84PPARG
SCHEMBL7171663 0.86 FAAH (0.46) ALDH1A1HSP90AA1FAAHHRH3MEN1
SCHEMBL3230247 0.78 HSP90AA1 (0.53) ALDH1A1HSP90AA1FAAHHRH3MEN1
SCHEMBL16620081 0.78 HSP90AA1 (0.53) ALDH1A1HSP90AA1FAAHHRH3MEN1
SCHEMBL8513443 0.78 HSP90AA1 (0.53) ALDH1A1HSP90AA1FAAHHRH3MEN1
SCHEMBL16620471 0.78 HRH3 (0.45) ALDH1A1HSP90AA1FAAHHRH3MEN1
SCHEMBL3902185 0.77 ALDH1A1 (0.53) ALDH1A1HSP90AA1FAAHHRH3MEN1
SCHEMBL8511093 0.76 HSP90AA1 (0.52) ALDH1A1HSP90AA1FAAHHRH3MEN1
SCHEMBL11589563 0.76 ALDH1A1 (0.51) ALDH1A1HSP90AA1FAAHHRH3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1292566-A2 PROCESS FOR HYDROLYZING AMIDO-CARBOXYLIC ACID ESTERS INTO AMIDO-CARBOXYLIC ACIDS EASTMAN CHEMICAL COMPANY (US) 2003-03-19 EP disclosed
US-6497644-B2 Process for recycling amido-carboxylic acid esters into amino-carboxylic acids EASTMAN CHEMICAL COMPANY 2002-12-24 US disclosed
US-20020052528-A1 Process for recycling amido-carboxylic acid esters into amido-carboxylic acids EASTMAN CHEMICAL COMPANY 2002-05-02 US disclosed
WO-2001092209-A2 PROCESS FOR HYDROLYZING AMIDO-CARBOXYLIC ACID ESTERS INTO AMIDO-CARBOXYLIC ACIDS EASTMAN CHEMICAL COMPANY (US) 2001-12-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020052528-A1 Process for recycling amido-carboxylic acid esters into amido-carboxylic acids APEH, NAAA, PARG ALDH1A1 2053/4885HSP90AA1 1051/4885FAAH 62/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.